Cargando…
Bullous pemphigoid and COVID-19 vaccine()
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529265/ https://www.ncbi.nlm.nih.gov/pubmed/34697598 http://dx.doi.org/10.1016/j.medcle.2021.05.004 |
| _version_ | 1784586433467514880 |
|---|---|
| author | Pérez-López, Israel Moyano-Bueno, David Ruiz-Villaverde, Ricardo |
| author_facet | Pérez-López, Israel Moyano-Bueno, David Ruiz-Villaverde, Ricardo |
| author_sort | Pérez-López, Israel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8529265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85292652021-10-21 Bullous pemphigoid and COVID-19 vaccine() Pérez-López, Israel Moyano-Bueno, David Ruiz-Villaverde, Ricardo Med Clin (Engl Ed) Letter to the Editor Elsevier España, S.L.U. 2021-11-26 2021-10-21 /pmc/articles/PMC8529265/ /pubmed/34697598 http://dx.doi.org/10.1016/j.medcle.2021.05.004 Text en © 2021 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Pérez-López, Israel Moyano-Bueno, David Ruiz-Villaverde, Ricardo Bullous pemphigoid and COVID-19 vaccine() |
| title | Bullous pemphigoid and COVID-19 vaccine() |
| title_full | Bullous pemphigoid and COVID-19 vaccine() |
| title_fullStr | Bullous pemphigoid and COVID-19 vaccine() |
| title_full_unstemmed | Bullous pemphigoid and COVID-19 vaccine() |
| title_short | Bullous pemphigoid and COVID-19 vaccine() |
| title_sort | bullous pemphigoid and covid-19 vaccine() |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529265/ https://www.ncbi.nlm.nih.gov/pubmed/34697598 http://dx.doi.org/10.1016/j.medcle.2021.05.004 |
| work_keys_str_mv | AT perezlopezisrael bullouspemphigoidandcovid19vaccine AT moyanobuenodavid bullouspemphigoidandcovid19vaccine AT ruizvillaverdericardo bullouspemphigoidandcovid19vaccine |